Baptist Health Doc-to-Doc

Epilepsy care has evolved dramatically in recent years. Advances in diagnostics, surgical techniques, and neuromodulation are transforming how physicians treat patients with drug-resistant epilepsy. In this episode of Baptist Health Doc to Doc, Neurosurgeon and System Chief Executive of Baptist Health Brain & Spine Care and Chief Medical Executive of Miami Neuroscience Institute, Dr. Michael M...

In this episode of Baptist Health Doc to Doc, Dr. John Diaz and Dr. Mehran Habibi discuss how artificial intelligence, robotic surgery, precision medicine, and targeted therapies are transforming breast cancer and gynecologic oncology in 2026. Topics include: - AI-assisted breast imaging and surgical planning - Robotic hysterectomy and minimally invasive cancer surgery - De-escalation of sentinel...

Join Joseph Panoff, M.D., radiation oncologist at Baptist Health Miami Cancer Institute, and Youssef Zeidan, M.D., radiation oncologist at Lynn Cancer Institute, for an in-depth physician-to-physician discussion on modern breast cancer radiation therapy. They explore how photon-based radiation has evolved over the last two decades—from early planning techniques to today’s highly conformal approach...

In this episode of Baptist Health’s Doc-to-Doc, we take a closer look at one of the most concerning trends in oncology — the rise of breast cancer among younger women. Dr. Anastasia Tousimis, Deputy Director of Baptist Health Cancer Care, sits down with Dr. Louise Morrell, Chief Medical Executive of Lynn Cancer Institute, to discuss what’s driving this gradual increase and how clinicians can bette...

In this Baptist Health Doc-to-Doc episode, Dr. Michael McDermott, Chief Medical Executive of Baptist Health Miami Neuroscience Institute sits down with Dr. Evan Bander, Neurosurgeon & Co-Director of  the Pituitary Tumor Program at the Baptist Health Miami Neuroscience Institue, to unpack the complexities of the body’s “master gland.”  Together, they explore how pituitary tumors are diagnosed a...

In this episode of Baptist Health's Doc-to-Doc, we explore the evolving landscape of arrhythmia care with host Tom Nguyen, M.D., Chief Medical Executive of Baptist Health Heart & Vascular Care, Director of Minimally Invasive Surgery, and Barry T. Katzen Endowed Chair at Miami Cardiac & Vascular Institute, and Professor and Chair of the Department of Cardiovascular Sciences at Florida...

In this episode of Doc to Doc, we explore groundbreaking advances in the treatment of blood cancers with two of the field’s leading experts: Dr. Guenther Koehne, Deputy Director and Chief of Blood and Marrow Transplant, Hematologic Oncology and Benign Hematology, and Dr. Firas El Chaer, Chief of Leukemia Services and Medical Director of Infusion — both from Baptist Health Miami Cancer Institute. F...

Why do thyroid cancers demand a more nuanced approach, despite high survival rates?   In this episode of Doc to Doc, Dr. Meghan Crawley, head and neck surgical oncologist at Miami Cancer Institute, joins Dr. Rachel Slotcavage, endocrine surgeon at Lynn Cancer Institute, to explore what makes thyroid cancers so unique and how treatment approaches are evolving.   From surgery and RAI therapy to targ...

What happens when landmark trials challenge long-standing surgical standards? In this episode of Doc to Doc, Dr. Thomas Morrissey, director of gynecologic oncology at Lynn Cancer Institute, joins Dr. Ryan Kahn, gynecologic oncologist at Miami Cancer Institute, to explore how data from pivotal studies like TRUST, SHAPE, and MIRASOL are redefining treatment decisions in gynecologic cancer. From resp...

What happens when we stop gatekeeping genetic testing and offer it universally?   In this episode of Doc to Doc, Dr. Arelis Martir Negron, medical geneticist at Miami Cancer Institute, joins Dr. Venkatappa to explore how the field of cancer genetics is transforming — and what every clinician should know. From BRCA1 and BRCA2 to multi-gene panels and AI-powered risk stratification, testing this con...

Brain tumors remain among the most complex and challenging conditions we confront. There are over 120 histologically distinct tumor types, with survival outcomes varying drastically depending on molecular profile and location. As a result, the need for nuanced, multidisciplinary care has never been more evident. While advances in neuroimaging, genomic profiling, and immunotherapy have shifted para...

Thanks for joining us today for this in-depth discussion on head and neck cancers, including oral cancer. In this episode, we explore the complexities of diagnosing, treating, and managing these challenging malignancies. With advancements in disease biology, artificial intelligence integration, robotic surgery, and biomarker-driven therapies, the treatment landscape has evolved, offering more pers...

Pancreatic cancer has been a lethal malignancy for too long. Available cytotoxic therapies for advanced disease are modestly effective with a 5-year survival rate, less than 15%, but new modalities using ablative radiation therapy holds promise in improving outcomes. Reports of ablative radiation therapy for pancreatic cancer using the 0.35 Tesla, MR Linac have resulted in promising local control...

Lung cancer has shown a decrease in incidence and mortality in recent decades; however, it remains one of the cancers with the highest incidence and still ranks first in cancer-related deaths in the United States. Advancements like molecular interpretation of lung cancer has substantially changed the classification and treatment of these tumors, becoming an essential component of pathologic diagno...

Uterine Transposition: Transforming Gynecologic Cancer Care and Fertility Preservation   Uterine transpositions represent a groundbreaking advancement in fertility preservation for women undergoing treatment for gynecologic cancers. Dr. John P. Diaz and Dr. Jean-Marie Stephan are at the forefront of this innovative surgery at Miami Cancer Institute, which involves temporarily relocating the uterus...

Aside from non-melanoma skin cancers, Prostate cancer, or PCa, is the most common cancer diagnosed for males in the United States and the second leading cause of cancer death for them. Its varying degrees of aggressiveness along with high incidence to mortality ratio, provide significant challenges for both patients and the medical community. However, the treatment landscape of PCa and its metasta...

Minimally Invasive Spine Surgery (MISS) of the lumbar spine is a type of surgery that uses smaller incisions that standard lumbar spine surgery.  Minimally Invasive Spine Surgery can result in less pain, faster recovery, and less damage to nearby muscles and tissue.  The advent of interactive navigation and intraoperative imaging have become an important part of accurate, efficient, and safe spine...

Inappropriate sinus tachycardia, also known as IST, is a condition of elevated sinus rate unassociated with known pathological, pharmacological, or physiological causes. Its diagnosis has been, in the past, missed or at times dismissed. It does not help that its definitions in current literature are inconsistent, and professional society consensus have had limited impact. Considering its broad set...

We could not be more exhilarated about the research led by investigators at Baptist Health Miami Cancer Institute. Several of our physician-researchers presented their studies at this year’s ASCO annual meeting in Chicago. Join us as we highlight many of our findings, because many of these landmark studies are transforming care, extending lives, and improving the quality of life of our patients. ...

Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of robotic-assisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination...

Join Drs. Michael McDermott and Nir Lipsman as they discuss focused ultrasound in neuroscience, how it started and the clinical research that brings us to where we are today and what the future holds.   Presenters:   Michael McDermott, M.D. Chief Medical Executive, Baptist Health Miami Neuroscience Institute Irma & Kalman Bass Endowed Chair in Clinical Neuroscience Nir Lipsman, M.D. Harquail C...

In the third and final episode of the series on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we will examine the advancements in left atrial appendage management and discuss what lies ahead in promising developments offering brilliant and never-imagined solutions.     Presenters:   Steven Hoff, M.D., a board-certified cardiac and thoracic surgeon at Baptist Health Miami Cardiac...

Join Michael McDermott, M.D., chief medical executive of Baptist Health Miami Neuroscience Institute, and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience, along with Manmeet Ahluwalia, M.D., MBA, FASCO, the chief of medical oncology, chief scientific officer & deputy director, and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute, as they...

Join Tom C. Nguyen, M.D., chief medical executive, director of minimally invasive valve surgery of Baptist Health Miami Cardiac & Vascular Institute, and Barry T. Katzen Endowed Chair, along with Nish Patel, M.D., an interventional cardiologist and Director of the Structural Heart Program at Baptist Health Miami Cardiac & Vascular Institute, as they discuss the future of AI in modern-day m...

 In the 2nd episode on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we are exploring surgical ablation, Endo/Epicardial Catheter approach for mapping and ablation of A-Fib. We will also visit the current oral anticoagulants and the Pre, Peri and Postprocedural usage of DOACs, NOACs and TSOAC.   Guests:   Steven Jeffrey Hoff , M.D., Cardiac and Thoracic Surgeon, Miami Cardiac &am...